Publications by authors named "Tahira Mattoo"

Study Objective: Polycystic ovary syndrome (PCOS), the most common endocrinopathy of women, is a state of chronic low-grade inflammation and is closely linked to type 2 diabetes mellitus and cardiovascular disease. Oral contraceptive pills (OCPs), is the usual first choice of treatment in women with PCOS. Because OCP use has been linked to the risk of venous thrombosis and there are limited data on the effect of OCP use on the inflammatory state of women with PCOS, our objective was to compare the levels of intercellular adhesion molecule (ICAM)-1, tumor necrosis factor (TNF)-α, and monocyte chemoattractant protein (MCP)-1 between drug-naive and OCP-treated women with PCOS.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Tahira Mattoo"

  • - Tahira Mattoo’s research primarily investigates the impact of oral contraceptive pills (OCPs) on inflammatory markers in women with polycystic ovary syndrome (PCOS), a condition that is associated with chronic low-grade inflammation and can lead to serious health issues like type 2 diabetes and cardiovascular disease.
  • - In her 2017 pilot study, Mattoo aimed to evaluate differences in plasma levels of intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor-α (TNF-α) between drug-naive women and those treated with OCPs.
  • - The findings from this study contribute to the understanding of OCPs' influence on inflammatory states in women with PCOS, highlighting the need for more comprehensive data on the long-term effects and risks associated with OCP usage in this patient population.